AKT1 and type 2 diabetes mellitus: In conclusion, our results suggest that HAS reduces blood glucose in the T2DM mouse model by regulating glycogen metabolism through a mechanism involving the regulation of the PI3K/Akt/GSK3β/GS signaling pathway.